Live Breaking News & Updates on Clinical Infectious Diseases Journal

Stay updated with breaking news from Clinical infectious diseases journal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ironwood's apraglutide wins in short bowel but CIC questioned

Positive phase III data from Ironwood Pharmaceuticals Inc. with once-weekly glucagon-like peptide-2 analogue apraglutide failed to impress Wall Street, and shares of the Boston-based firm (NASDAQ:IRWD) closed Feb. 29 at $9.43, down $5.69, or 37.6%. The experiment called Stars tested apraglutide to reduce parenteral support in adults with short bowel syndrome with intestinal failure. Rare and severe, the condition affects about 18,000 adults in the U.S., Europe and Japan. Based on the latest data, Ironwood plans to submit an NDA to the U.S. FDA and other regulatory filings. ....

Boston , Massachusetts , United-states , Japan , Nasdaq , Ironwood-pharmaceuticals-inc , Ironwood-pharmaceuticals , Wall-street , Ironwood-pharmaceuticals-inc , Apraglutide , Short-bowel-syndrome

Me-two drug? Viking mid-stage trial wins with GLP-1/GIP bid

The enticing prospect – and proven worth – of dually agonizing the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors gained more evidence in a big way from Viking Therapeutics Inc. with VK-2735 in a phase II weight loss study. Shares of San Diego-based Viking Therapeutics Inc. (NASDAQ:VKTX) closed Feb. 27 at $85.05, up $46.57, or 121%, as investors learned that the drug achieved the primary and all secondary endpoints in the phase II study called Venture, with significant body-weight drops at all doses compared to placebo. ....

Nasdaq , San-viking-therapeutics-inc , Therapeutics-inc , Viking-therapeutics , San-diego-based-viking-therapeutics , Viking-therapeutics-inc , Vk-2735 , Glp-1 , Gip , Bioworld , Clinical

BEYOND CHEMO AND CLINICAL TRIALS

SocietyBreast cancer, a pervasive global health concern, is increasingly making its presence felt among young women in the subcontinent. While traditionally perceived as a disease affecting older age groups, recent trends point to a disturbing rise. ....

New-delhi , Delhi , India , Karachi , Sindh , Pakistan , Dhaka , Bangladesh , Sri-lanka , Nepal , Sara-danial , World-health-organization

What is Informed Consent?

Informed consent represents one of the most important ethical aspects of clinical treatments and scientific research involving humans. ....

Greece , United-states , United-kingdom , America , Satyanarayana-rao , Pressmaster-shutterstock , Intj-environ-res-public-health , Oxford-university , Johns-hopkins-university , Oxford-university-press , Silent-world , Johns-hopkins-university-press

Is Alzheimer's the same as dementia? A brain expert explains

A breakthrough new drug to treat brain disease is always welcome news. Last summer, the performance of the drugs donanemab and lecanemab in clinical trials. ....

United-kingdom , Germany , German , Alois-alzheimer , David-cox , Regulatory-agency , Alzheimer-research-united-kingdom , Research-united-kingdom , Is , Alzheimers , The , Same